Press Releases

Product specially formulated with novel orally dissolving film technology.

As flu cases continue to remain high, select CVS pharmacies across 37 states launch combo test for Flu A, Flu B and COVID-19

Dr. Reddy’s gets exclusive rights to commercialize the subcutaneous as well as intravenous formulations of HLX15 in the U.S. and Europe

Four New Members from Diverse Health Care Professions, Organizations and Industries Join Board

Says the discount card company is colluding with the named PBMs to fix reimbursements

Investigation finds massive middlemen significantly hike patient costs for lifesaving drugs, skim billions for themselves, and reimburse their own pharmacies more than their competitors.

Funding supports critical community pharmacy advocacy efforts to elevate and sustain the pharmacy profession.

Bortezomib for Injection is a proteasome inhibitor indicated for treatment of adult patients with multiple myeloma and treatment of adult patients with mantle cell lymphoma.

Congress fumbled a chance to rein in big insurance and PBMs and save taxpayers billions, says NCPA

The big three PBMs rake in billions from government drug programs while patients pay more and small pharmacies are squeezed out, says NCPA

PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models

Dicyclomine Hydrochloride Capsules, USP are an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome.

But Congress must ignore big insurance and the PBM lobby’s last-ditch effort to scuttle reforms and pass the continuing resolution

Erlotinib Tablets are available in 25 mg, 100 mg, and 150 mg strengths, packaged in 30-count bottles.

Featuring 1% and 2% concentrations, this versatile product is available in various vial and pack sizes to meet diverse healthcare needs.